Eralp, Y. Et Al. 2008. MAPK overexpression is associated with anthracycline resistance and increased risk for recurrence in patients with triple-negative breast cancer. Annals of Oncology , vol.19, no.4 , 669-674.

Eralp, Y., Derin, D., ÖZLÜK, M. Y., Yavuz, E., Guney, N., SAİP, P. M., ... Muslumanoglu, M.(2008). MAPK overexpression is associated with anthracycline resistance and increased risk for recurrence in patients with triple-negative breast cancer. Annals of Oncology , vol.19, no.4, 669-674.

Eralp, YEŞİM Et Al. "MAPK overexpression is associated with anthracycline resistance and increased risk for recurrence in patients with triple-negative breast cancer," Annals of Oncology , vol.19, no.4, 669-674, 2008

Eralp, YEŞİM Et Al. "MAPK overexpression is associated with anthracycline resistance and increased risk for recurrence in patients with triple-negative breast cancer." Annals of Oncology , vol.19, no.4, pp.669-674, 2008

Eralp, Y. Et Al. (2008) . "MAPK overexpression is associated with anthracycline resistance and increased risk for recurrence in patients with triple-negative breast cancer." Annals of Oncology , vol.19, no.4, pp.669-674.

@article{article, author={YEŞİM ERALP Et Al. }, title={MAPK overexpression is associated with anthracycline resistance and increased risk for recurrence in patients with triple-negative breast cancer}, journal={Annals of Oncology}, year=2008, pages={669-674} }